Moreover, we find that both mRNA and protein level of CHD1 in glioma cells were evidently diminished after treating miR‐200b/c/429 mimics while both levels of it were enhanced after miR‐200b/c/429 inhibition (Figure S2C‐G). Here, CHD1 is linked to central nervous system cancer.